Navigation Links
Genedata Screener Extends Support for High-Throughput Thermofluor Assays
Date:9/3/2013

Basel, Switzerland (PRWEB) September 03, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the latest developments of Genedata Screener® will be shown in the European Laboratory Robotics Interest Group (ELRIG) 7th Annual Drug Discovery Conference. An ELRIG poster session will present a collaborative project with Bayer Pharma, which resulted in “A Novel Data Processing Workflow for Efficient Analysis of Large-Scale Thermofluor Assays.” Genedata Screener will also demonstrate its Compound Synergy and High Content Screening extensions during the ELRIG conference in Manchester, England (Booth F; Central Convention Centre; September 3-4).

The latest enhancements to Genedata Screener strengthen its capabilities as a premier data analysis platform for label-free technologies, in particular, enabling rapid assessment of a protein’s thermal stability under a variety of conditions. Using Genedata Screener, pharmaceutical companies can scale-up thermal shift assays and integrate them into existing screening data analysis workflows, reducing data analysis time from days to hours.

Thermal Shift Analysis Goes High-Throughput with Analysis Time Reduced by 80%
The Thermofluor assay, also referred to as Thermal Shift Analysis (TSA) or Differential Scanning Fluorimetry (DSF), is becoming widely-used for diverse applications in drug discovery, including: selection of suitable formulations for therapeutic antibodies; evaluation of additives and ligands for (co-) crystallization experiments; and identification of small molecule modulators of soluble targets and characterization of their binding mode. To run TSA in high-throughput, data analysis software must enable fast and accurate processing of melting curves without time-consuming manual reviews. Genedata Screener uniquely provides these capabilities for TSA in high-throughput mode.

Genedata Screener helps pharmaceutical companies realize the full value of label-free technologies such as TSA. It has been shown to effectively eliminate time-consuming and inaccurate manual processes by automatically processing and synoptically compiling results. Specific quality metrics highlight curves requiring review and direct visual access to curves enables instantaneous curve analysis. Its flexible and accurate data analysis platform can scale from the smallest datasets to thousands of plates in 96-, 384- and 1536-well formats with full time/temperature resolution. In TSA/DSF experiments, Genedata Screener visualization capabilities help to optimize the temperature window by enabling scientists to review overlays of hundreds of melting curves.

Genedata Screener provides a single platform for capturing, analyzing, and managing all types of screening data. It reduces data processing times by upwards to 80% and integrates with any plate-based instrument to support screening at all throughputs, as well as High Content-, Ion Channel-, and Label-free screening technologies. Genedata Screener also allows detailed analyses of cell sub-population changes and compound synergy effects, giving researchers a standardized platform on which they can efficiently visualize and explore compound combinations at unprecedented processing speed and with unsurpassed result quality.

“More than half of the top 25 pharmaceutical companies already rely on Genedata Screener to support a wide variety of plate-based screening technologies, making it the platform of choice for all types of screening data analysis,” said Dr. Othmar Pfannes, CEO of Genedata. “With the latest developments, we demonstrate our commitment to continuously invest in supporting new technologies, which ultimately increases the ROI on Genedata Screener for our customers.”

ELRIG Editorial Note: Genedata Poster Session: September 3 - 4:00 pm - 5:00pm CET. “A Novel Data Processing Workflow for Efficient Analysis of Large-Scale Thermofluor Assays” by Stephan Steigele1*°, Jörg Weiske2*, Stephan Heyse1, and Amaury Fernández-Montalván2° (1Genedata AG, Basel, Switzerland, 2Bayer Pharma AG, Berlin, Germany). To schedule a briefing, contact jackie(dot)thrasivoulos(at)genedata(dot)com.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11060452.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata at ESACT Announces Expansion Into Biopharma Process Development
2. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
3. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
4. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
5. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
6. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
7. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
8. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
9. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
10. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
11. Genedata Screener for HCS Advances Phenotypic Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):